Market Cap

SK Biopharmaceuticals Co. Ltd Market Capitalization:

₩7.338 Trillion

KRW as of July 1, 2025

US$5.41 Billion

business SK Biopharmaceuticals Co. Ltd Company Profile

SK Biopharmaceuticals Co. Ltd Main Stock Listing

KRX: 326030

Market Capitalization History of SK Biopharmaceuticals Co. Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $309.91 B
Vertex Pharmaceuticals Incorporated $117.36 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $59.14 B
Marinomed Biotech AG $58.56 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of SK Biopharmaceuticals Co. Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2025 ₩8.591 T 12.86%
Jan. 1, 2024 ₩7.612 T 38.86%
Jan. 1, 2023 ₩5.482 T -6.46%
Jan. 1, 2022 ₩5.861 T -47.72%
Jan. 1, 2021 ₩11.211 T

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

SK Biopharmaceuticals Co. Ltd Categories

South Korea languages Healthcare languages Biotechnology
South Korea Healthcare South Korea Biotechnology

Stocks & Indices

SK Biopharmaceuticals Co. Ltd has the following listings and related stock indices.


Stock: KRX: 326030

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.